Another young lifter’s roid cycle has become a cautionary tale after his own social media posts documented a physique that got worse, not better, once he started using gear. The teen, named Faith Paneto, posted a video claiming his lack of recent pictures was due to being on a “dirty bulk,” a video that inadvertently exposed the true timeline of his cycle.
Before ever posting a “first month on gear” video, he had already shared content dated to what would have been the actual start of his roid use. At that point in the timeline, no results from the PEDs could have possibly been achieved, since it takes roughly three to four weeks for blood serum levels to fully saturate before any accumulation of results even begins.
Yet the physique shown in that early clip was already lean, tapered at the waist, and free of any breast tissue enlargement, suggesting a solid natural foundation before any d[]ug use began.
What followed was a steady decline. Rather than building a leaner, more muscular frame, he appeared to power bulk his way up to 163 lbs (about 74 kg), ending up looking worse than his starting point.
Gynecomastia, the development of male breast tissue, visibly worsened once he began his cycle, a change tied to the way testosterone converts to estrogen through the aromatase enzyme, which is produced more heavily in fat tissue. The more body fat present, the more substrate is available for that conversion.
Compounding the issue was his reported use of Trenbolone, a roid known for raising prolactin levels. Prolactin receptors exist in male breast tissue, and when prolactin binds to those sites, it can trigger an alternate pathway for gynecomastia development separate from estrogen alone. That same pathway is involved in stimulating milk-producing cells, which in rare cases can lead to actual lactation in men using the compound, a rarely discussed side effect of anabolic roid use.
Recent research adds further concern about Trenbolone specifically. A 2026 study of over 1,100 men found that those using Tren reported higher rates of irritability, unstable moods, and depressive symptoms compared to PED users who avoided it, with those depressive symptoms often persisting long term rather than fading after the cycle ended.
